You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 4, April 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (18)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Articles for Residents
 •Ophthalmology, Other
 •Alert me on articles by topic

Rate of Visual Field Loss in Progressive Glaucoma

Marga T. E. Rasker, MD; Aad van den Enden, MSc; Douwe Bakker; Philip F. J. Hoyng, MD, PhD

Arch Ophthalmol. 2000;118:481-488.

Objective  To investigate the rate of visual field (VF) loss in progressive glaucoma.

Setting  Outpatient department, nonreferral base.

Methods  A cohort of 34 patients with normal-pressure glaucoma (NPG), 68 patients with primary open-angle glaucoma (POAG), and 125 patients with ocular hypertension (OHT) were followed up for an average of 9 years. Visual fields were obtained annually with automated perimetry. The rate of VF loss as a percentage per year was calculated.

Results  Twenty-three eyes with NPG, 31 with POAG, and 10 with OHT showed progression of VF loss. The mean (±SD) rates of VF deterioration were 3.7% ± 3.3% per year in NPG, 2.5% ± 1.8% in POAG, and 2.3% ± 1.3% in OHT converting to POAG, and did not differ significantly. No difference in the rate of VF loss was found between eyes with and without optic disc hemorrhages (2.7% ± 2.9% and 3.1% ± 2.1%, respectively). The rate of VF loss was not related to the initial VF status. The rate of VF loss between the superior and inferior hemifields was correlated in patients with NPG (rs=0.67, P=.04). Comparison of visual field loss with linear regression analysis showed significant slopes in only 37.5% of eyes with progression, which had a progression rate of 4.2% ± 3.0%.

Conclusions  The rate of VF loss did not differ between patients with NPG and POAG. The rate of deterioration was related neither to initial VF status nor to the presence of disc hemorrhages. Linear regression is applicable only in a portion of the patients who have progression of VF loss.


From the Netherlands Ophthalmic Research Institute (Drs Rasker and Hoyng and Mr van den Enden), St Lucas Hospital (Dr Hoyng), and Glaucoma Department, Academic Medical Center (Drs Rasker and Hoyng and Mr Bakker), Amsterdam, the Netherlands.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Glaucoma and Fitness to Drive: Using Binocular Visual Fields to Predict a Milestone to Blindness
Owen et al.
IOVS 2008;49:2449-2455.
ABSTRACT | FULL TEXT  

Estimating the Rate of Progressive Visual Field Damage in Those with Open-Angle Glaucoma, from Cross-Sectional Data
Broman et al.
IOVS 2008;49:66-76.
ABSTRACT | FULL TEXT  

Comparative Study of Retinal Nerve Fiber Layer Measurement by StratusOCT and GDx VCC, II: Structure/Function Regression Analysis in Glaucoma
Leung et al.
IOVS 2005;46:3702-3711.
ABSTRACT | FULL TEXT  

Normal Visual Field Test Results Following Glaucomatous Visual Field End Points in the Ocular Hypertension Treatment Study
Keltner et al.
Arch Ophthalmol 2005;123:1201-1206.
ABSTRACT | FULL TEXT  

Optical Coherence Tomography Longitudinal Evaluation of Retinal Nerve Fiber Layer Thickness in Glaucoma
Wollstein et al.
Arch Ophthalmol 2005;123:464-470.
ABSTRACT | FULL TEXT  

Glaucomatous Visual Field Progression with Frequency-Doubling Technology and Standard Automated Perimetry in a Longitudinal Prospective Study
Haymes et al.
IOVS 2005;46:547-554.
ABSTRACT | FULL TEXT  

Pointwise Linear Regression for Evaluation of Visual Field Outcomes and Comparison With the Advanced Glaucoma Intervention Study Methods
Nouri-Mahdavi et al.
Arch Ophthalmol 2005;123:193-199.
ABSTRACT | FULL TEXT  

A New Role for Diode Laser Transscleral Cyclophotocoagulation?
Wilson
Arch Ophthalmol 2001;119:424-425.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.